Heterogeneity of Survival Benefit Conferred by Letermovir. (PubMed, Transplant Cell Ther) - May 1, 2025 - "Our models successfully identified patients who could be expected to experience lower NRM with LTV prophylaxis, underscoring the importance of personalized medicine."
Heterogeneity • Journal • Cytomegalovirus Infection • Transplantation
|
|
Hideki Nakasone; Jun Ishikawa; Katsuto Takenaka; Keisuke Kataoka; Kimikazu Yakushijin; Koji Kawamura; Makoto Onizuka; Masashi Sawa; Masatsugu Tanaka; Naoki Kurita; Naoyuki Uchida; Noriko Doki; Shin-Ichiro Fujiwara; Shinichi Kako; Takahide Ara; Takahiro Fukuda; Tetsuya Nishida; Wataru Takeda; Yoshiko Atsuta; Yoshinobu Kanda; Yu Akahoshi; Yuma Tada; Yuta Hasegawa
|